Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dcc7d7259def30e33dbf2ba33a42672 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-74 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-721 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
filingDate |
2012-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a49f012afdf1343b25a68769f5e650 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f42a373dd0f587c896d6049a5c2e0b2 |
publicationDate |
2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2012110336-A |
titleOfInvention |
Chimeric retinoid X receptors and their use in novel ecdysone receptor-based inducible gene expression systems |
abstract |
Novel ecdysone receptor / chimeric retinoid X receptor-based inducible gene expression system and gene therapy, large-scale production of proteins and antibodies, cell-based high-throughput screening assays, functional genomics and transgenics Methods of modulating gene expression in a host cell for applications such as modulation of properties in an organism are provided. I) transactivation domains; and ii) a) vertebrate RXR helix 1-6 and invertebrate RXR helix 7-12; b) vertebrate RXR helix 1-7 and invertebrate RXR. Or c) an isolated polypeptide encoding a hybrid polypeptide comprising a chimeric retinoid X receptor ligand binding domain comprising helix 1-8 of vertebrate RXR and helix 9-12 of invertebrate RXR. nucleotide. [Selection] Figure 6 |
priorityDate |
2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |